Eikon Therapeutics CEO to Participate in November Investor Conferences
CEO Roger M. Perlmutter is scheduled to participate in the Guggenheim 3rd Annual Healthcare Innovation conference.
CEO Roger M. Perlmutter is scheduled to participate in the Guggenheim 3rd Annual Healthcare Innovation conference.